Origen de la red de primer grado Jeff Fellows.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 11 | |
| Public Company | Pharmaceuticals: Other | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jeff Fellows a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Sales & Marketing | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Equipment/Instruments | Director/Board Member | |
| IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Chief Executive Officer | |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| Queen's University | College/University | Undergraduate Degree | |
| Haverford College | College/University | Undergraduate Degree | |
| Kansas State University | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| The University of Colorado | College/University | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Thoracic Society, Inc.
 American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Meridian Engineering Co.
 Meridian Engineering Co. Engineering & ConstructionIndustrial Services Meridian Engineering Co. provides construction services. It specializes in heavy/civil, structural and industrial construction. The company was founded by Ted Haworth and Mark Sutton in 2003 and is headquartered in Tucson, AZ. | Engineering & Construction | Corporate Officer/Principal | |
| Sauder School of Business | College/University | Masters Business Admin | |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
Mazza Innovation Ltd.
 Mazza Innovation Ltd. Food: Specialty/CandyConsumer Non-Durables Mazza Innovation Ltd. provides plant extraction technology. Its products include PhytoClean which yields clean ingredients in an earth-friendly manner from plants. The company was founded by Giuseppe Mazza, Carl Pronyk, and Eduardo Cacace in August 2011 and is headquartered Delta, Canada. | Food: Specialty/Candy | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
HighLife SAS
 HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
| School of Mining Engineering UNSW | College/University | Graduate Degree | |
| RADIENT TECHNOLOGIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer | |
| TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Bast Fibre Technologies, Inc.
 Bast Fibre Technologies, Inc. TextilesProcess Industries Bast Fibre Technologies, Inc. engages in the production of plant-based natural fibres. The firm's process of making products include agronomics, decortication, wet processing, and fibre modification. Its products include baby wipes, personal care, household wipes, and commercial wipes. The company is headquartered in Victoria, Canada. | Textiles | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
Contextual Health
 Contextual Health BiotechnologyHealth Technology Contextual Health is a Canadian cancer genomics company that distributes genetic tests and computational systems. Michael Ball has been the CEO of the company since 2019. | Biotechnology | Director/Board Member | |
The Flowr Group, Inc.
 The Flowr Group, Inc. Pharmaceuticals: OtherHealth Technology The Flowr Group, Inc. manufactures and distributes medical cannabis. The company was founded by Tom Flow, Steven A. Klein and David Miller. It is headquartered in Markham, Canada. | Pharmaceuticals: Other | Chief Operating Officer | |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director-Back Office Operation | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
| FRESH TRACKS THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
| Immunoflex Therapeutics, Inc. | Chief Executive Officer | ||
Canexia Health, Inc. (Canada)
 Canexia Health, Inc. (Canada) Medical/Nursing ServicesHealth Services Canexia Health, Inc. is a Canadian company founded in 2012 by Chris Wagner and David Huntsman. The private company is based in Vancouver, Canada. Canexia Health provides oncology services. | Medical/Nursing Services | Chief Executive Officer | |
| Lake Country Health Planning Society | President | ||
Ariceum Therapeutics GmbH
 Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| Pet Therapy, Inc. | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 24 |
| Canadá | 15 |
| Alemania | 4 |
| Francia | 3 |
| Israel | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Finance | 3 |
| Process Industries | 3 |
Operativa
| Director/Board Member | 98 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 35 |
| Chief Executive Officer | 16 |
| Founder | 13 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Olivier Litzka | 21 |
| Derek DiRocco | 17 |
| Daphne Karydas | 16 |
| Glenn Sblendorio | 15 |
| Chris Wagner | 10 |
| David Rodman | 10 |
| Adam Levy | 10 |
| Jon Conlin | 9 |
| Jon Congleton | 8 |
| Lisa Ranken | 8 |
| Benjamin Lightburn | 6 |
| Konstantin Adamsky | 6 |
| Minji Kim | 5 |
| BT Slingsby | 4 |
- Bolsa de valores
- Insiders
- Jeff Fellows
- Conexiones Empresas